BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 24436421)

  • 21. Identification of the first duplication in MYH9-related disease: a hot spot for unequal crossing-over within exon 24 of the MYH9 gene.
    De Rocco D; Pujol-Moix N; Pecci A; Faletra F; Bozzi V; Balduini CL; Savoia A
    Eur J Med Genet; 2009; 52(4):191-4. PubMed ID: 19450438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function.
    Li Y; Friedmann DR; Mhatre AN; Lalwani AK
    Cell Motil Cytoskeleton; 2008 May; 65(5):393-405. PubMed ID: 18330899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actin and myosin contribute to mammalian mitochondrial DNA maintenance.
    Reyes A; He J; Mao CC; Bailey LJ; Di Re M; Sembongi H; Kazak L; Dzionek K; Holmes JB; Cluett TJ; Harbour ME; Fearnley IM; Crouch RJ; Conti MA; Adelstein RS; Walker JE; Holt IJ
    Nucleic Acids Res; 2011 Jul; 39(12):5098-108. PubMed ID: 21398640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cells.
    Liu Z; Van Rossen E; Timmermans JP; Geerts A; van Grunsven LA; Reynaert H
    J Hepatol; 2011 Jan; 54(1):132-41. PubMed ID: 20932596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion.
    Léon C; Eckly A; Hechler B; Aleil B; Freund M; Ravanat C; Jourdain M; Nonne C; Weber J; Tiedt R; Gratacap MP; Severin S; Cazenave JP; Lanza F; Skoda R; Gachet C
    Blood; 2007 Nov; 110(9):3183-91. PubMed ID: 17664350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease.
    Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY
    Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin.
    Huang Y; Shi H; Zhou H; Song X; Yuan S; Luo Y
    Blood; 2006 May; 107(9):3564-71. PubMed ID: 16403913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A.
    Zhang Y; Conti MA; Malide D; Dong F; Wang A; Shmist YA; Liu C; Zerfas P; Daniels MP; Chan CC; Kozin E; Kachar B; Kelley MJ; Kopp JB; Adelstein RS
    Blood; 2012 Jan; 119(1):238-50. PubMed ID: 21908426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis.
    Nangia-Makker P; Shekhar MPV; Hogan V; Balan V; Raz A
    Oncotarget; 2022; 13():534-550. PubMed ID: 35309869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity.
    Sanborn KB; Mace EM; Rak GD; Difeo A; Martignetti JA; Pecci A; Bussel JB; Favier R; Orange JS
    Blood; 2011 Nov; 118(22):5862-71. PubMed ID: 22123909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Animal models of MYH9 disorders].
    Suzuki N; Kunishima S; Naoe T; Matsushita T
    Rinsho Ketsueki; 2013 Nov; 54(11):2031-7. PubMed ID: 24305535
    [No Abstract]   [Full Text] [Related]  

  • 32. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.
    Pecci A; Klersy C; Gresele P; Lee KJ; De Rocco D; Bozzi V; Russo G; Heller PG; Loffredo G; Ballmaier M; Fabris F; Beggiato E; Kahr WH; Pujol-Moix N; Platokouki H; Van Geet C; Noris P; Yerram P; Hermans C; Gerber B; Economou M; De Groot M; Zieger B; De Candia E; Fraticelli V; Kersseboom R; Piccoli GB; Zimmermann S; Fierro T; Glembotsky AC; Vianello F; Zaninetti C; Nicchia E; Güthner C; Baronci C; Seri M; Knight PJ; Balduini CL; Savoia A
    Hum Mutat; 2014 Feb; 35(2):236-47. PubMed ID: 24186861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder.
    Zaninetti C; De Rocco D; Giangregorio T; Bozzi V; Demeter J; Leoni P; Noris P; Ryhänen S; Barozzi S; Pecci A; Savoia A
    Hamostaseologie; 2019 Feb; 39(1):87-94. PubMed ID: 29996171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes.
    Arrondel C; Vodovar N; Knebelmann B; Grünfeld JP; Gubler MC; Antignac C; Heidet L
    J Am Soc Nephrol; 2002 Jan; 13(1):65-74. PubMed ID: 11752022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonmuscle myosin IIA is required for lamellipodia formation through binding to WAVE2 and phosphatidylinositol 3,4,5-triphosphate.
    Morimura S; Suzuki K; Takahashi K
    Biochem Biophys Res Commun; 2011 Jan; 404(3):834-40. PubMed ID: 21184743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulated proteolysis of nonmuscle myosin IIA stimulates osteoclast fusion.
    McMichael BK; Wysolmerski RB; Lee BS
    J Biol Chem; 2009 May; 284(18):12266-75. PubMed ID: 19269977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation.
    Eckly A; Strassel C; Freund M; Cazenave JP; Lanza F; Gachet C; Léon C
    Blood; 2009 Apr; 113(14):3182-9. PubMed ID: 18984861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines.
    Burns JE; Baird MC; Clark LJ; Burns PA; Edington K; Chapman C; Mitchell R; Robertson G; Soutar D; Parkinson EK
    Br J Cancer; 1993 Jun; 67(6):1274-84. PubMed ID: 8390283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonmuscle myosin IIA-dependent force inhibits cell spreading and drives F-actin flow.
    Cai Y; Biais N; Giannone G; Tanase M; Jiang G; Hofman JM; Wiggins CH; Silberzan P; Buguin A; Ladoux B; Sheetz MP
    Biophys J; 2006 Nov; 91(10):3907-20. PubMed ID: 16920834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer.
    Liang S; He L; Zhao X; Miao Y; Gu Y; Guo C; Xue Z; Dou W; Hu F; Wu K; Nie Y; Fan D
    PLoS One; 2011 Apr; 6(4):e18409. PubMed ID: 21533124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.